OPTIMIZING A NOVEL INTRADUCTAL DELIVERY OF CALCINEURIN INHIBITORS AS A RADIO-CONTRAST INFUSION FORMULATION TO PREVENT POST-ERCP PANCREATITIS

The Leland Stanford Junior University

Investigators